Review: Prolactin and Gonadal Hormones: A Key Relationship That May Have Clinical,Monitoring and Therapeutic Implications in Systemic Lupus Erythematosus
Restricted accessReview articleFirst published online April, 1993
Review: Prolactin and Gonadal Hormones: A Key Relationship That May Have Clinical,Monitoring and Therapeutic Implications in Systemic Lupus Erythematosus
Riddle O.Prolactin in vertebrate function and organization. J Natl Cancer Inst1933; 31: 1039.
2.
Nagy E., Berczi I.Immunodeficiency in hypophysectomized rats. Acta Endocrinol1979 ; 89: 530-7.
3.
Berczi I., Nagy E., Kovakas K. et al. Regulation of humoral immune response in rats by pituitary hormones . Acta Endocrinol (Copenhagen)1981; 98: 506-13.
4.
Rusell DH, Matrisian L., Kiebler R. et al. Prolactin receptors on human lymphocytes and their modulation by cyclosporine. Biochem Biophys Res Commun1984; 121: 899-906.
5.
Clevenger Chv , Altmann SW, Pristowsky MBRequirement of nuclear prolactin for interleukin-2 stimulated proliferation of T lymphocytes. Science1991; 253: 77-9.
6.
Talal N., Ansar ASImmunomodulation by hormones-an area of growing importance. J Rheumatol1987 ; 14: 191-3 (editorial).
7.
Lavalle C.Prolactin — a hormone with immunoregulatory properties that leads to new therapeutic approaches in rheumatic diseases. J Rheumatol1992; 19: 839-41 (editorial).
8.
Jara LJ, Lavalle C., Fraga A. et al. Prolactin, immunoregulation, and autoimmune diseases. Sem Arthritis Rheum1991; 20: 273-84.
9.
Boyar RM, Kapen S., Finkelstein JW et al. Hypothalamic-pituitary function in diverse hyperprolactinemic states. J Clin Invest1974; 53: 1588-97.
10.
Ansar AS, Penhale WJ, Talal N.Sex hormones, immune and autoimmune responses. Mechanisms of sex hormone action. Am J Pathol1985; 121: 531-59.
11.
Nokin J., Vekemans M., L'Hermite M., Robyn C.Circadian periodicity of serum prolactin concentration in man. Br Med J1972; 3: 561.
12.
Vrontakis ME , Thilveris JA, Friesen HGInfluence of bromocriptine and oestrogen on prolactin synthesis, secretion and tumor growth in vivo in rats. J Endocrinol1987; 113: 383.
13.
Haug E.Progesterone suppression of estrogen-stimulated prolactin secretion and estrogen receptor levels in rat pituitary cells. Endocrinology1979; 104: 429.
14.
Murdoch GH, Franco R., Evans RM, Rosenfeld MGPolypeptide hormone regulation of gene expression: thyrotropin-releasing hormone rapidly stimulates both transcription of the prolactin gene and the phosphorylation of a specific nuclear protein. J Biol Chem1983; 258: 15329.
15.
Gautvik KM, Kriz M.Effects of prostaglandins on prolactin and growth hormone synthesis and secretion in culture rat pituitary cells. Endocrinology1976; 98: 352.
16.
Bjoro T., Ostberg BC, Sand O. et al. Vasoactive intestinal peptide and peptide with N-terminal histidine and C-terminal isoleucine increase prolactin secretion in cultured rat pituitary cells (GH4C1) via a cAMP-dependent mechanism which involves transient elevation of intracellular Ca2+. Mol Cell Endocrinol1987; 49: 119.
Stanley F.Stimulation of prolactin gene expression by insulin. J Biol Chem1988; 263: 13444.
19.
Maurer RADopaminergic inhibition of prolactin synthesis and prolactin messenger RNA accumulation in cultured pituitary cells. J Biol Chem1980; 255: 8092.
20.
Davis Jre, Lynam TC, Franklyn JA, Docherty K., Shepperd MCTri-iodothyronine and phenytoin reduce prolactin messenger RNA levels in cultured rat pituitary cells. J Endocrinol1986; 109: 359.
21.
Carrillo AJ , Pool TB, Sharp ZDVasoactive intestinal peptide increases prolactin messenger ribonucleic acid content in GH3 cells. Endocrinology1985; 116: 202.
22.
Vekemans M. , Robyn C.The influence of exogenous estrogen on the circadian periodicity of circulating prolactin in women. J Clin Endocrinol Metab1975; 40: 886-9.
23.
Walker SE, McMurray RW, Besch-Williford CL, Keisler DHPremature death with bladder outlet obstruction and hyperprolactinemia in New Zealand Black x New Zealand White mice treated with ethinyl estradiol and 17 beta-estradiol. Arthritis Rheum1992 ; 35: 1387-91.
24.
Lahita RG, Bradlow HL, Fishaman J. et al. Estrogen metabolism in systemic lupus erythematosus. Arthritis Rheum1982; 25: 843-6.
25.
Lavalle C., Loyo E., Paniagua R. et al. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol1987; 14: 268-72.
26.
Roubinian JR , Talal N., Greenspan JS et al. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies and glomerulonephritis in NZB x NZW F1 mice. J Exp Med1978; 147: 168-73.
27.
Jara LJ, Graef A., Lavalle C.Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus . J Rheumatol1991; 18: 349-53.
28.
Wilson JTAltered rat hepatic drug metabolism after implantation of a pituitary mammotropic tumor (MtT), Walker carcinosarcoma or adenocarcinoma and after removal of the MtT. Endocrinology1971 ; 88: 185-94.
29.
Fang VS, Refetoff S., Rosenfield RLHypogonadism induced by a transplantable, prolactin producing tumor in male rats: hormonal and morphological studies. Endocrinology1974; 95: 991-8.
30.
Adler RAThe anterior pituitary-grafted rat: a valid model of chronic hyperprolactinemia . Endocr Rev1986; 7: 302-13.
31.
Adler RA, Krieg RJ, Farrell ME, Deiss WP, MacLeod RMCharacterization of a new animal model of chronic hyperprolactinemia . Metabolism1991; 40: 286-91.
32.
Judd AM, Login IS, Kovacs K. et al. Characterization of the MMQ cell, a prolactin-secreting clonal cell line that is responsive to dopamine. Endocrinology1988; 123: 2341-50.
33.
Bethea CL, Hess DL, Ronnekieiv H., Freesh F.Reproductive hormone levels after pituitary allograft in Cyclosporin-treated monkeys. Fertility Sterility1991; 56: 754-63.
34.
Cheung CYProlactin suppresses luteinizing hormone secretion and pituitary responsiveness to luteinizing hormone-releasing hormone by a direct action at the anterior pituitary. Endocrinology1983; 112: 632-8.
35.
Kslow RA, Masi ATAge, sex, and race effects on mortality from systemic lupus erythematosus in the United States. Arthritis Rheum1978 ; 21: 473-9.
36.
Mintz G., Niz J., Gutierrez G. et al. Prospective study of pregnancy in systemic lupus erythematosus . J Rheumatol1986 ; 13: 732-9.
37.
Petri M., Howard D., Repke J.Frequency of lupus flare in pregnancy: the Hopkins Lupus Pregnancy Center experience. Arthritis Rheum1991; 34: 1538-45.
38.
Stem R., Fishman J., Brusman H. et al. Systemic lupus erythematosus associated with Klinefelter's syndrome . Arthritis Rheum1977; 20: 18-22.
39.
Juneja HS, Karanth S., Dutt A., Parte P., Meherjee P.Diurnal variations and temporal coupling of bioactive and immunoactive luteinizing hormone, prolactin, testosterone and 17-beta-estradiol in adult men. Hormone Research1991; 35: 3-4.
40.
Tyson JE, Hwang P., Guyda H., Friesen HGStudies of prolactin secretion in human pregnancy. Am J Obstet Gynecol1972; 113: 14-20.
41.
Rigg LA, Lein A., Yen Ssc.Pattern of increase in circulating prolactin levels during human gestation . Am J Obstet Gynecol1977; 129: 454-6.
42.
Andersen JRProlactin in amniotic fluid and maternal serum during uncomplicated human pregnancy. Dan Med Bull1982; 29: 266-74.
43.
Jara LJ, Gomez-Sanchez C., Silveira L., Martinez-Osuna P., Vasey F., Espinoza L.Hyperprolactinemia in systemic lupus erythematosus: association with disease activity. Am J Med Sci1992; 303: 222-6.
44.
McMurray R. , Keisler D., Kanuckel K., Izui S., Walker SEProlactin influences autoimmune disease activity in the female B/W mouse. J Immunol1991 ; 147: 3780-7.
The Study Group of Hyperprolactinemia.Survey of infants born to mothers treated with bromocriptine. Presented at the Study Group meeting, Osaka , Japan, 1985.